Global C-Reactive Protein Test Market 2019-2023 | Evolving Opportunities with Abbott and Danaher | Technavio
LONDON--(BUSINESS WIRE)--Feb 25, 2020--
Technavio has been monitoring the global C-reactive protein test market since 2018 and the market is poised to grow by USD 110.41 million during 2019-2023, progressing at a CAGR of more than 1% during the forecast period. Request free sample pages
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20200225005475/en/
Technavio has announced its latest market research report titled Global C-Reactive Protein Test Market 2019-2023 (Graphic: Business Wire)
Read the 119-page report with TOC on “C-Reactive Protein Test Market Analysis Report by End-Users (Hospitals, Clinical laboratories, and Others), Geography (Asia, Europe, North America, and ROW), and the Segment Forecasts, 2019-2023”.
The market is driven by the increasing number of initiatives that support protein research. In addition, technological advances are anticipated to boost the growth of the C-reactive protein test market.
Governments across the world are undertaking various initiatives to increase the applications of protein research and production. For instance, in 2015, a consortium of experts from the Forum for the Future initiated the project, Protein Challenge 2040 in the UK. The project is aimed at developing a strong coalition of biotechnology companies, research institutions, and government organizations to advance protein research. Such initiatives are increasing the demand for products used in protein research, thereby necessitating the need for C-reactive protein tests.
Buy 1 Technavio report and get the second for 50% off. Buy 2 Technavio reports and get the third for free.
Major Five C-Reactive Protein Test Market Companies:
Abbott operates its business through segments such as Established Pharmaceuticals, Nutritionals, Diagnostics, Cardiovascular and Neuromodulation, and Other. NycoCard CRP is the key offering of the company.
Danaher operates its business through segments such as Life sciences, Diagnostics, Dental, and Environmental & Applied Solutions. OSR6147 is the key product offered by the company. It is a system reagent used for the determination of CRP in human serum.
F Hoffmann-La Roche Ltd
F Hoffmann-La Roche Ltd operates its business through segments such as Pharmaceutical and Diagnostics. Tina-quant C-Reactive Protein Gen.3 is the key offering of the company.
Merck KGaA operates its business through segments such as Healthcare, Life Science, and Performance Materials. CYT298 is the key offering of the company. It is offered as a test kit for the measurement of CRP in humans.
Thermo Fisher Scientific Inc.
Thermo Fisher Scientific Inc. operates its business through segments such as Life Sciences Solutions, Analytical Instruments, Specialty Diagnostics, and Laboratory Products and Services. CRP Human ELISA Kit is the key offering of the company.
Register for a free trial today and gain instant access to 17,000+ market research reports.
Technavio has segmented the C-reactive protein test market based on the end-users and region.
C-Reactive Protein Test End-Users Outlook (Revenue, USD Million, 2019 - 2023)
- Clinical Laboratories
C-Reactive Protein Test Regional Outlook (Revenue, USD Million, 2019 - 2023)
- North America
Technavio’s sample reports are free of charge and contain multiple sections of the report, such as the market size and forecast, drivers, challenges, trends, and more.Request a free sample report
Related Reports on Healthcare are:
Global Anti-Thrombin III Testing Market – Global anti-thrombin III testing market by end-users (hospitals, laboratories, and academic and research institutes) and geography (Asia, Europe, North America, and ROW).
Global Vitamin D Testing Market – Global vitamin D testing market by geography (Asia, Europe, North America, and ROW), product (25-hydroxyvitamin D testing and 1,25-dihydroxyvitamin D testing), and end-users (diagnostic laboratories, hospitals and physician clinics, and home care settings).
Technavio is a leading global technology research and advisory company. Their research and analysis focus on emerging market trends and provides actionable insights to help businesses identify market opportunities and develop effective strategies to optimize their market positions.
With over 500 specialized analysts, Technavio’s report library consists of more than 17,000 reports and counting, covering 800 technologies, spanning across 50 countries. Their client base consists of enterprises of all sizes, including more than 100 Fortune 500 companies. This growing client base relies on Technavio’s comprehensive coverage, extensive research, and actionable market insights to identify opportunities in existing and potential markets and assess their competitive positions within changing market scenarios.
If you are interested in more information, please contact our media team at email@example.com
View source version on businesswire.com:https://www.businesswire.com/news/home/20200225005475/en/
CONTACT: Technavio Research
Media & Marketing Executive
US: +1 844 364 1100
UK: +44 203 893 3200
INDUSTRY KEYWORD: CONSULTING PROFESSIONAL SERVICES HEALTH OTHER HEALTH
SOURCE: Technavio Research
Copyright Business Wire 2020.
PUB: 02/25/2020 07:00 AM/DISC: 02/25/2020 07:01 AM